Medicare Enrolled

Dr. Zade Shaw, MD

Neurology · Dalton, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1107 MEMORIAL DR STE 300, Dalton, GA 30720
7062756121
In practice since 2017 (9 years)
NPI: 1124556568 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shaw from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shaw? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shaw

Dr. Zade Shaw is a neurology specialist in Dalton, GA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Shaw performed 12,414 Medicare services across 724 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shaw received a total of $10,483 from 50 pharmaceutical and/or device companies across 584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shaw is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 9% volume in GA $10,483 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,414
Medicare services
Top 9% in GA for neurology
724
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,379 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
11,425 $5 $27
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
293 $69 $376
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
262 $82 $309
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
129 $171 $1,043
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
128 $106 $468
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
50 $151 $920
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
37 $23 $155
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
29 $107 $624
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
24 $92 $588
Psychiatric diagnostic evaluation
A clinical assessment conducted by a psychiatrist to evaluate a patient's mental health status and determine a diagnosis.
13 $80 $630
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
13 $122 $807
Continuous EEG brain wave monitoring
A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously.
11 $174 $900
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,483
Total received (2021-2024)
Avg $2,621/year across 4 years
Top 25% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
584
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,368 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$115 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,609
2023
$3,397
2022
$2,916
2021
$561

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$653
UCB, Inc.
$490
PFIZER INC.
$366
Novartis Pharmaceuticals Corporation
$184
CSL Behring
$182
ACADIA Pharmaceuticals Inc
$169
Neurocrine Biosciences, Inc.
$143
EMD Serono, Inc.
$114
Alexion Pharmaceuticals, Inc.
$114
Genentech USA, Inc.
$101
MDD US Operations, LLC
$101
Alnylam Pharmaceuticals Inc.
$98
Teva Pharmaceuticals USA, Inc.
$95
Biogen, Inc.
$93
Neurelis, Inc.
$83
ARGENX US, INC.
$78
Kyowa Kirin, Inc.
$76
Eisai Inc.
$58
Lilly USA, LLC
$50
TG Therapeutics, Inc.
$44
Lundbeck LLC
$40
Amgen Inc.
$36
SCILEX PHARMACEUTICALS INC.
$35
Celgene Corporation
$31
SK Life Science, Inc.
$31
Octapharma USA, Inc.
$28
JAZZ PHARMACEUTICALS INC.
$25
Ipsen Biopharmaceuticals, Inc
$24
Sumitomo Pharma America, Inc.
$20
Acorda Therapeutics, Inc
$18
AstraZeneca Pharmaceuticals LP
$15
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 41.8% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,089
UCB, Inc.
$963
PFIZER INC.
$559
Novartis Pharmaceuticals Corporation
$535
Celgene Corporation
$530
AbbVie Inc.
$514
Biogen, Inc.
$475
ACADIA Pharmaceuticals Inc
$449
Alexion Pharmaceuticals, Inc.
$351
Neurelis, Inc.
$344
Lilly USA, LLC
$341
CSL Behring
$299
Biohaven Pharmaceutical Holding Company Ltd.
$297
Neurocrine Biosciences, Inc.
$284
Teva Pharmaceuticals USA, Inc.
$263
Kyowa Kirin, Inc.
$216
Eisai Inc.
$212
Janssen Pharmaceuticals, Inc
$200
GENZYME CORPORATION
$199
ARGENX US, INC.
$187
EMD Serono, Inc.
$185
Supernus Pharmaceuticals, Inc.
$172
MDD US Operations, LLC
$168
Genentech USA, Inc.
$166
SK Life Science, Inc.
$153
AstraZeneca Pharmaceuticals LP
$130
Lundbeck LLC
$127
Merz Pharmaceuticals, LLC
$98
Alnylam Pharmaceuticals Inc.
$98
Octapharma USA, Inc.
$85
IMPEL PHARMACEUTICALS INC.
$83
Amgen Inc.
$79
Banner Life Sciences, LLC
$73
Acorda Therapeutics, Inc
$58
BANNER LIFE SCIENCES, LLC
$48
Avion Pharmaceuticals
$45
TG Therapeutics, Inc.
$44
Sumitomo Pharma America, Inc.
$44
UPSHER-SMITH LABORATORIES LLC
$36
Scilex Pharmaceuticals Inc.
$35
Allergan, Inc.
$35
SCILEX PHARMACEUTICALS INC.
$35
MITSUBISHI TANABE PHARMA AMERICA, INC.
$33
Amneal Pharmaceuticals LLC
$27
JAZZ PHARMACEUTICALS INC.
$25
Ipsen Biopharmaceuticals, Inc
$24
Boston Scientific Corporation
$20
Corium, LLC
$19
EISAI INC.
$19
Horizon Therapeutics plc
$13
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AJOVY · AMVUTTRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · DUOPA · Dhivy · Dysport · EMGALITY · EPIDIOLEX · Enspryng · Fabhalta · Fintepla · Fycompa · GOCOVRI · General - DBS · Gocovri · Hizentra · INBRIJA · INGREZZA · KESIMPTA · Leqembi · MAYZENT · Mavenclad · NOURIANZ · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · Ponvory · QULIPTA · RADICAVA · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · Soliris · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Dalton?
Compare neurologists in the Dalton area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
5
Per 100K population
4.8
County median income
$64,262
Nearest hospital
HAMILTON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shaw is a mixed practice specialist, with above-average Medicare volume (top 9% in GA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shaw experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Shaw performed 11,425 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shaw receive payments from pharmaceutical companies?
Yes. Dr. Shaw received a total of $10,483 from 50 companies across 584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shaw's costs compare to other neurologists in Dalton?
Dr. Shaw's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shaw) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →